Cargando…

Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”

Detalles Bibliográficos
Autores principales: Vrachatis, Dimitrios A., Giotaki, Sotiria G., Giannopoulos, George, Deftereos, Spyridon, Reimers, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471533/
https://www.ncbi.nlm.nih.gov/pubmed/32880807
http://dx.doi.org/10.1007/s40265-020-01395-9
_version_ 1783578788044472320
author Vrachatis, Dimitrios A.
Giotaki, Sotiria G.
Giannopoulos, George
Deftereos, Spyridon
Reimers, Bernhard
author_facet Vrachatis, Dimitrios A.
Giotaki, Sotiria G.
Giannopoulos, George
Deftereos, Spyridon
Reimers, Bernhard
author_sort Vrachatis, Dimitrios A.
collection PubMed
description
format Online
Article
Text
id pubmed-7471533
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-74715332020-09-04 Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19” Vrachatis, Dimitrios A. Giotaki, Sotiria G. Giannopoulos, George Deftereos, Spyridon Reimers, Bernhard Drugs Letter to the Editor Springer International Publishing 2020-09-03 2020 /pmc/articles/PMC7471533/ /pubmed/32880807 http://dx.doi.org/10.1007/s40265-020-01395-9 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Vrachatis, Dimitrios A.
Giotaki, Sotiria G.
Giannopoulos, George
Deftereos, Spyridon
Reimers, Bernhard
Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
title Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
title_full Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
title_fullStr Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
title_full_unstemmed Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
title_short Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
title_sort comment on: “pharmaco-immunomodulatory therapy in covid-19”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471533/
https://www.ncbi.nlm.nih.gov/pubmed/32880807
http://dx.doi.org/10.1007/s40265-020-01395-9
work_keys_str_mv AT vrachatisdimitriosa commentonpharmacoimmunomodulatorytherapyincovid19
AT giotakisotiriag commentonpharmacoimmunomodulatorytherapyincovid19
AT giannopoulosgeorge commentonpharmacoimmunomodulatorytherapyincovid19
AT deftereosspyridon commentonpharmacoimmunomodulatorytherapyincovid19
AT reimersbernhard commentonpharmacoimmunomodulatorytherapyincovid19